Document # | Medical Policy Title |
SURG.00143 | Perirectal Spacers for Use During Prostate Radiotherapy |
The AIM Clinical Appropriateness Guidelines for Radiation Therapy address brachytherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.
OPEN THE GUIDELINES FOR RADIATION THERAPY EFFECTIVE MARCH 13, 2022
For commercial and Medicare members
COMING SOON RADIATION THERAPY GUIDELINES EFFECTIVE NOVEMBER 6, 2022
The AIM Clinical Appropriateness Guidelines for Proton Beam Therapy address proton beam therapy, also known as proton radiation therapy or proton radiotherapy.
OPEN THE GUIDELINES FOR PROTON BEAM THERAPY EFFECTIVE MARCH 13, 2022
The AIM Clinical Appropriateness Guidelines for Perirectal Hydrogel Spacer address the use of an implanted hydrogel spacer when radiation therapy is used to treat prostate cancer.
COMING SOON PERIRECTAL HYDROGEL SPACER GUIDELINES EFFECTIVE NOVEMBER 6, 2022
For guidelines older than 3 years, please contact AIM.guidelines@aimspecialtyhealth.com